Nikko Asset Management Americas, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.64 Billion
- Q3 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 9,694,778 shares of RXRX stock, worth $59.9 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
9,694,778
Previous 9,934,491
2.41%
Holding current value
$59.9 Million
Previous $74.5 Million
14.25%
% of portfolio
0.74%
Previous 0.87%
Shares
14 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$203 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$156 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$107 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$95.1 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.12B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...